These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
Gymnema sylvestre a Potential Inhibitor of COVID-19 Main Protease by MD simulation Study.pdf (1.29 MB)

Gymnema Sylvestre A- Potential Inhibitor of COVID-19 Main Protease by MD Simulation Study

submitted on 20.05.2020, 09:16 and posted on 21.05.2020, 06:03 by Senthil Kumar Subramani, Yash Gupta, Manish Manish, GBKS Prasad
Gymnema sylvestre (GS) is one of the herbal plant used since in ancient times. The present study aimed to assess bioactive compounds GS mainly gymnemic acids as potential inhibitors for COVID-19 against Mpro enzyme using a molecular docking study. The docking score observed between -53.4 to - 42.4 of all gymnemic acids and its derivatives. Molecular Dynamics (MD) simulation studies carried out at 100ns supported the stability of GS molecules within the binding pocket. RMSD score of less than 3.6. mainly, our results supported that these GS molecules bind to the domain I & II, and domain II-III linker of 3CLpro enzyme, suggesting its suitability as strong candidate for therapeutic against COVID-19.


No funding received for this study


Email Address of Submitting Author


Jiwaji University



ORCID For Submitting Author


Declaration of Conflict of Interest

The authors declare that there is no conflict of interest associated with this manuscript.